ArticleTargeted oncology2019

Addition of Bevacizumab to First-Line Palliative Chemotherapy in Patients with Metastatic Small Bowel Adenocarcinoma: A Population-Based Study.

Laura M Legué et al.PubMed ↗Publisher ↗

No numbers read from the abstract.